➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKesson
Moodys
Boehringer Ingelheim
Mallinckrodt

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 8,126,143

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,126,143
Title:Apparatus and method for improving in-game communications during a game
Abstract: The present invention is directed to an apparatus for improving communications between players and coaches during a sporting event, more specifically allowing players to dynamically receive real-time communications from their coaches concerning intended game plays to be effected on the field or court. Said game apparatus comprises of a transparent, protective top cover having the same contour as a middle portion, wherein said middle portion is provided with a display element, and wherein said top cover, middle portion and the display element are all enclosed by a rear cover forming a housing for a receiving means for receiving an encrypted signal of an intended game play from a portable remote terminal, and wherein said top cover, middle portion, display element and housing are positioned on an upper portion of an elasticized band, which has an extended flap, wherein said extended flap includes a closing means used to secure the game apparatus and to conceal the display element from public view.
Inventor(s): Daniel; Isaac S. (Miami, FL), Stibila; Michael (Lake Mary, FL)
Assignee: ID Coach, LLC (Miramar, FL)
Application Number:12/286,476
Patent Claims:see list of patent claims

Details for Patent 8,126,143

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial ID Coach, LLC (Miramar, FL) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,126,143

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.